technical work
intracellular delivery of proteins
High Efficiency Delivery of Proteins
new intracellular delivery system
high yield delivery of nano
ERC Advanced Grant funding
Nucleic Acids
comprehensive market analysis
ERC PoC
robust evidence of market
robust business plan
report
final business plan
Human Cells
substantial funding
mammalian cell types
pluripotent stem cell culture
customers
problem
expression of mRNA
Professor Shakesheff's team
face-to-face meetings
potential partners
exemplification
advantages
differentiation
pluripotency
consideration of manufacturing routes
European marketing company
reprogramming tool
confidential discussions
product launches
microparticles
INTRASTEM
challenngng pharmaceutical applications
costs of goods
commercial feasibility
independent freedom
non-viral strategies
Concept Application
GAG
deliverables
enhanced transduction
approaches
view
commercialisation
competitor products
Proof
licenses
account
lentiviral transfection
target markets